Abstract
Breast cancer is a leading death cause in women globally. Since therapeutic products do not yet approach the tumor tissue at adequate levels; therefore, nanoparticle-based chemotherapy has been explored nowadays. Implementing nanotechnology to the treatment of breast cancer renders chemotherapy very successful and efficacious but far less toxic. In this review article, literature about polymeric nanoparticles applications in breast cancer was retrieved from PubMed, ScienceDirect, and Google Scholar databases. This review paper briefly addresses molecular targets in breast cancer's pathophysiology, drawbacks of current therapies for breast cancer, and polymeric nanoparticles as an evolving breast cancer chemotherapy that includes benefits, critical characteristics, and passive and active tumor targeting via polymeric nanoparticles. An outline of progression in polymeric nanoparticles for breast cancer treatment reports in current publications; patents available and clinical trials conducted for breast cancer in the last few years have been reviewed briefly.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
